Peripheral/Endo

New Meta-Analysis Presented at American College of Cardiology Strongly Supports RenalGuard(R) Use in Cardiovascular Interventional Procedures

MILFORD, MA — (Marketwired) — 03/22/17 — A new meta-analysis presented this week at the American College of Cardiology further supports the ability of RenalGuard Therapy® to significantly reduce the incidence of acute kidney injury associated with cardiovascular interventional procedures compared to other methods of urine volume expansion. Moreover, findings […]

Intact Vascular Announces Completion of Enrollment in the Tack Optimized Balloon Angioplasty II (TOBA II) Clinical Trial

WAYNE, Pa.–(BUSINESS WIRE)– Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that its Tack Optimized Balloon Angioplasty II (TOBA II) clinical trial has completed enrollment. A total of 210 patients have been enrolled in TOBA II at 33 sites in the U.S. […]

Perflow Medical Announces Issuance of Patent for The Stream™ Dynamic Neuro-Thrombectomy Net to Improve Thrombus Removal Post-Stroke

NEWS PROVIDED BY Perflow Medical 07 Dec, 2016, 08:05 ET SHARE THIS ARTICLE TEL AVIV, Israel, Dec. 7, 2016 /PRNewswire/ — Perflow Medical, an Israeli-based medtech company focused on next-generation neurointerventional devices, today announced the issuance of U.S. Patent No. 9510855, by the U.S. Patent and Trademark Office (USPTO), for […]

Innovative Cardiovascular Solutions Announces Successful First Cases in European Clinical Study of EMBLOK Embolic Protection System

NEWS PROVIDED BY Innovative Cardiovascular Solutions 15 Mar, 2017, 15:09 ET SHARE THIS ARTICLE MILAN, March 15, 2017 /PRNewswire/ — Innovative Cardiovascular Solutions (ICS), a privately held medical device company pioneering novel solutions for embolic protection during transcatheter aortic valve replacement (TAVR), announced today successful first European clinical cases using the […]

PQ Bypass Announces CE Mark for DETOUR Percutaneous Bypass Technologies

PQ Bypass Announces CE Mark for DETOUR Percutaneous Bypass Technologies Trio of proprietary technologies expands treatment options for patients with extremely long superficial femoral artery blockages due to peripheral artery disease March 13, 2017 08:00 AM Eastern Daylight Time SUNNYVALE, Calif.–(BUSINESS WIRE)–PQ Bypass, today announced CE (Conformité Européenne) Mark approval […]

AV Medical’s Chameleon receives expanded indication to include infusion of diagnostic or therapeutic fluids

TEL AVIV, Israel–(BUSINESS WIRE) AV Medical Technologies announced on 27 February 2017 that its Chameleon PTA balloon catheter has received FDA clearance for an expanded indication to include infusion of diagnostic or therapeutic fluids. “The Chameleon balloon offers advantages for experienced operators as well as those training in dialysis access […]

Medtronic Launches Below-The-Knee Clinical Study in Europe for Treatment of PAD Using New Drug-Coated Balloon Technology

Press Release DUBLIN – Mar. 9, 2017 – Medtronic plc (NYSE: MDT) today announced the launch of the IN.PACT(TM) BTK study to evaluate the effectiveness of using a drug-coated balloon (DCB) in patients with below-the-knee (BTK) peripheral arterial disease (PAD). This study will evaluate the IN.PACT 0.014 paclitaxel-coated percutaneous transluminal angioplasty […]

Keystone Heart Applauds FDA Advisory Panel for Recognition of The Need for Cerebral Protection Following TAVR

CAESAREA, Israel and TAMPA, Fla., Feb. 27, 2017 /PRNewswire/ — Keystone Heart Ltd., an emerging medical device company focused on developing cerebral embolic protection devices for patients undergoing cardiac procedures, applauds the members of the FDA’s Circulatory System Devices Panel that convened this past week for their acknowledgement of the […]

CEO and Co-founder of Renova Therapeutics to present at Novel Cardiovascular Therapeutics Summit

SAN DIEGO, Feb. 27, 2017 /PRNewswire-USNewswire/ — Renova™ Therapeutics, a biotechnology company developing gene therapy treatments for congestive heart failure and type 2 diabetes, announced that the company’s CEO and Co-founder, Jack W. Reich, Ph.D., will be speaking at the Novel Cardiovascular Therapeutics Summit in San Francisco on February 28, […]